James Kelly, Assistant Professor of Radiopharmaceutical Sciences in Radiology
Background & Unmet Need
- Radiopharmaceuticals using alpha-emitting isotopes like Ac-225 are emerging as powerful therapeutic tools for treating cancer
- Current quality control methods using radioHPLC or radioTLC alone cannot accurately assess the purity of complex alpha-emitting compounds
- Rapid, accurate purity verification is critical for patient safety and regulatory compliance in radiopharmaceutical production
- Manual handling of radioactive samples increases personnel exposure risks
- Unmet Need: A standardized method of accurate and rapid quality control analysis of complex radiopharmaceuticals that does not compromise analytical precision and minimizes radiation exposure
Technology Overview
- The Technology: An integrated HPLC-radioTLC analysis platform for precise radiopharmaceutical quality control
- The platform features a chemically resistant moving stage with protective cover, compatible with multiple radioTLC scanner models
- The system uses disposable inserts with absorption-lined wells to prevent cross-contamination
- PoC Data: A working prototype has been validated across multiple radionuclides (225Ac and 134Ce) and diverse radiopharmaceutical types including small molecules, peptides, antibodies, and nanoparticles.
- The platform demonstrates rapid analysis times (~30 minutes) while maintaining robust analytical integrity
Technology Applications
- Quality control analysis in GMP radiopharmaceutical manufacturing
- Clinical radiopharmacy operations requiring standardized QC procedures
- Analysis of novel radiotherapeutics in research settings
Technology Advantages
- Enables precise identification of radiolabeled compounds and their impurities
- Reduces operator radiation exposure through improved handling design
- Compatible with existing radioTLC equipment through versatile stage design
- Accommodates both manual and automated fraction collection methods

Figure: Prototype of the integrated HPLCradioTLC platform showing the 3D-printed customizable moving stage with disposable insert installed in a commercial radioTLC scanner.
Resources
Intellectual Property
Patents
- Provisional Application Filed
Cornell Reference
- 11437
Contact Information

For additional information please contact
Donna Rounds
Associate Director, Business Development and Licensing
Phone: (646) 962-7044
Email: djr296@cornell.edu